The medical world is witnessing a major shift in blood sugar therapy with the introduction of GLP-1 transdermal devices. These patches offer a potentially more user-friendly alternative to subcutaneous administrations of GLP-1 receptor agonists, lessening the need for daily needle pokes. The approach administers the drug directly through the ski… Read More